Concresco Pharma Technologies Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 10-12-2024
- Paid Up Capital ₹ 0.10 M
as on 10-12-2024
- Company Age 1 Year 4 Months
- Last Filing with ROC 31 Mar 2024
About Concresco Pharma Technologies
The Company is engaged in the Paper Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Krishanakant Gandhi, Srinivas Irukulla, and Venkata Irukulla serve as directors at the Company.
- CIN/LLPIN
U21009TS2023PTC176081
- Company No.
176081
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Aug 2023
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Concresco Pharma Technologies?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Srinivas Irukulla  | Managing Director | 16-Aug-2023 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Krishanakant Gandhi | Director | 16-Aug-2023 | Current |
| Venkata Irukulla | Director | 16-Aug-2023 | Current |
Financial Performance of Concresco Pharma Technologies.
Enhance accessibility to Concresco Pharma Technologies's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Concresco Pharma Technologies?
Unlock access to Concresco Pharma Technologies's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Wiwin Health Care Private LimitedActive 2 years 11 monthsKrishanakant Gandhi, Srinivas Irukulla and 1 more are mutual person
- Sri Rama Surya Constructions Private LimitedActive 3 years 3 months
Venkata Irukulla is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Concresco Pharma Technologies?
Unlock and access historical data on people associated with Concresco Pharma Technologies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Concresco Pharma Technologies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Concresco Pharma Technologies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
